![Molecular Therapeutics of Pancreatic Ductal Adenocarcinoma: Targeted Pathways and the Role of Cancer Stem Cells: Trends in Pharmacological Sciences Molecular Therapeutics of Pancreatic Ductal Adenocarcinoma: Targeted Pathways and the Role of Cancer Stem Cells: Trends in Pharmacological Sciences](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/ef311ad6-dc30-4221-b212-d271e86c1b8d/gr1_lrg.jpg)
Molecular Therapeutics of Pancreatic Ductal Adenocarcinoma: Targeted Pathways and the Role of Cancer Stem Cells: Trends in Pharmacological Sciences
![Prognostic relevance of molecular subtypes and master regulators in pancreatic ductal adenocarcinoma – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on CyberLeninka open science Prognostic relevance of molecular subtypes and master regulators in pancreatic ductal adenocarcinoma – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on CyberLeninka open science](https://cyberleninka.org/viewer_images/663204/f/1.png)
Prognostic relevance of molecular subtypes and master regulators in pancreatic ductal adenocarcinoma – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on CyberLeninka open science
![Pancreatic Ductal Deletion of Hnf1b Disrupts Exocrine Homeostasis, Leads to Pancreatitis, and Facilitates Tumorigenesis - Cellular and Molecular Gastroenterology and Hepatology Pancreatic Ductal Deletion of Hnf1b Disrupts Exocrine Homeostasis, Leads to Pancreatitis, and Facilitates Tumorigenesis - Cellular and Molecular Gastroenterology and Hepatology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/56233f7a-15d5-4b97-aa87-ca38351b0eef/fx1.jpg)
Pancreatic Ductal Deletion of Hnf1b Disrupts Exocrine Homeostasis, Leads to Pancreatitis, and Facilitates Tumorigenesis - Cellular and Molecular Gastroenterology and Hepatology
![Different shades of pancreatic ductal adenocarcinoma, different paths towards precision therapeutic applications - Annals of Oncology Different shades of pancreatic ductal adenocarcinoma, different paths towards precision therapeutic applications - Annals of Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/d99d9042-431c-4569-9c97-f4bc3eceac1d/gr1_lrg.jpg)
Different shades of pancreatic ductal adenocarcinoma, different paths towards precision therapeutic applications - Annals of Oncology
![LLGL1 Regulates Gemcitabine Resistance by Modulating the ERK-SP1-OSMR Pathway in Pancreatic Ductal Adenocarcinoma - Cellular and Molecular Gastroenterology and Hepatology LLGL1 Regulates Gemcitabine Resistance by Modulating the ERK-SP1-OSMR Pathway in Pancreatic Ductal Adenocarcinoma - Cellular and Molecular Gastroenterology and Hepatology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/d6046bfe-9bed-48ad-8220-042729ff91b2/fx1_lrg.jpg)
LLGL1 Regulates Gemcitabine Resistance by Modulating the ERK-SP1-OSMR Pathway in Pancreatic Ductal Adenocarcinoma - Cellular and Molecular Gastroenterology and Hepatology
![Molecular biology in pancreatic ductal adenocarcinoma: implications for future diagnostics and therapy | SpringerLink Molecular biology in pancreatic ductal adenocarcinoma: implications for future diagnostics and therapy | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs10353-019-0575-z/MediaObjects/10353_2019_575_Fig2_HTML.png)
Molecular biology in pancreatic ductal adenocarcinoma: implications for future diagnostics and therapy | SpringerLink
![Frontiers | Pancreatic Ductal Adenocarcinoma: A Strong Imbalance of Good and Bad Immunological Cops in the Tumor Microenvironment | Immunology Frontiers | Pancreatic Ductal Adenocarcinoma: A Strong Imbalance of Good and Bad Immunological Cops in the Tumor Microenvironment | Immunology](https://www.frontiersin.org/files/Articles/370474/fimmu-09-01044-HTML/image_m/fimmu-09-01044-g001.jpg)
Frontiers | Pancreatic Ductal Adenocarcinoma: A Strong Imbalance of Good and Bad Immunological Cops in the Tumor Microenvironment | Immunology
![Prognostic and predictive value of a five-molecule panel in resected pancreatic ductal adenocarcinoma: A multicentre study - EBioMedicine Prognostic and predictive value of a five-molecule panel in resected pancreatic ductal adenocarcinoma: A multicentre study - EBioMedicine](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/cdc52edd-1ff8-49c0-9582-70ebb8592e45/gr1_lrg.jpg)
Prognostic and predictive value of a five-molecule panel in resected pancreatic ductal adenocarcinoma: A multicentre study - EBioMedicine
![TP63-Mediated Enhancer Reprogramming Drives the Squamous Subtype of Pancreatic Ductal Adenocarcinoma - ScienceDirect TP63-Mediated Enhancer Reprogramming Drives the Squamous Subtype of Pancreatic Ductal Adenocarcinoma - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2211124718316401-fx1.jpg)
TP63-Mediated Enhancer Reprogramming Drives the Squamous Subtype of Pancreatic Ductal Adenocarcinoma - ScienceDirect
![Implementing biological markers as a tool to guide clinical care of patients with pancreatic cancer - ScienceDirect Implementing biological markers as a tool to guide clinical care of patients with pancreatic cancer - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1936523320304575-gr4.jpg)
Implementing biological markers as a tool to guide clinical care of patients with pancreatic cancer - ScienceDirect
![Molecular, morphological and survival analysis of 177 resected pancreatic ductal adenocarcinomas (PDACs): Identification of prognostic subtypes | Scientific Reports Molecular, morphological and survival analysis of 177 resected pancreatic ductal adenocarcinomas (PDACs): Identification of prognostic subtypes | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fsrep41064/MediaObjects/41598_2017_Article_BFsrep41064_Fig1_HTML.jpg)
Molecular, morphological and survival analysis of 177 resected pancreatic ductal adenocarcinomas (PDACs): Identification of prognostic subtypes | Scientific Reports
![Pathways of Progression From Intraductal Papillary Mucinous Neoplasm to Pancreatic Ductal Adenocarcinoma Based on Molecular Features - Gastroenterology Pathways of Progression From Intraductal Papillary Mucinous Neoplasm to Pancreatic Ductal Adenocarcinoma Based on Molecular Features - Gastroenterology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/171e83e1-2d23-4e7a-989d-bef19ece6e1f/fx1.jpg)
Pathways of Progression From Intraductal Papillary Mucinous Neoplasm to Pancreatic Ductal Adenocarcinoma Based on Molecular Features - Gastroenterology
![Pancreatic ductal adenocarcinoma: biological hallmarks, current status, and future perspectives of combined modality treatment approaches | Radiation Oncology | Full Text Pancreatic ductal adenocarcinoma: biological hallmarks, current status, and future perspectives of combined modality treatment approaches | Radiation Oncology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13014-019-1345-6/MediaObjects/13014_2019_1345_Fig3_HTML.png)
Pancreatic ductal adenocarcinoma: biological hallmarks, current status, and future perspectives of combined modality treatment approaches | Radiation Oncology | Full Text
![Pancreatic ductal adenocarcinoma: biological hallmarks, current status, and future perspectives of combined modality treatment approaches | Radiation Oncology | Full Text Pancreatic ductal adenocarcinoma: biological hallmarks, current status, and future perspectives of combined modality treatment approaches | Radiation Oncology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13014-019-1345-6/MediaObjects/13014_2019_1345_Fig5_HTML.png)
Pancreatic ductal adenocarcinoma: biological hallmarks, current status, and future perspectives of combined modality treatment approaches | Radiation Oncology | Full Text
![The molecular biology of pancreatic adenocarcinoma: translational challenges and clinical perspectives | Signal Transduction and Targeted Therapy The molecular biology of pancreatic adenocarcinoma: translational challenges and clinical perspectives | Signal Transduction and Targeted Therapy](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41392-021-00659-4/MediaObjects/41392_2021_659_Fig1_HTML.png)
The molecular biology of pancreatic adenocarcinoma: translational challenges and clinical perspectives | Signal Transduction and Targeted Therapy
![Epithelial to mesenchymal plasticity and differential response to therapies in pancreatic ductal adenocarcinoma | PNAS Epithelial to mesenchymal plasticity and differential response to therapies in pancreatic ductal adenocarcinoma | PNAS](https://www.pnas.org/content/116/52/26835/F1.large.jpg)
Epithelial to mesenchymal plasticity and differential response to therapies in pancreatic ductal adenocarcinoma | PNAS
![Identification and Interaction Analysis of Molecular Markers in Pancreatic Ductal Adenocarcinoma by Integrated Bioinformatics Analysis and Molecular Docking Experiments | medRxiv Identification and Interaction Analysis of Molecular Markers in Pancreatic Ductal Adenocarcinoma by Integrated Bioinformatics Analysis and Molecular Docking Experiments | medRxiv](https://www.medrxiv.org/content/medrxiv/early/2020/12/23/2020.12.20.20248601/F15.large.jpg)
Identification and Interaction Analysis of Molecular Markers in Pancreatic Ductal Adenocarcinoma by Integrated Bioinformatics Analysis and Molecular Docking Experiments | medRxiv
![Single-cell analysis of pancreatic ductal adenocarcinoma identifies a novel fibroblast subtype associated with poor prognosis but better immunotherapy response | Cell Discovery Single-cell analysis of pancreatic ductal adenocarcinoma identifies a novel fibroblast subtype associated with poor prognosis but better immunotherapy response | Cell Discovery](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41421-021-00271-4/MediaObjects/41421_2021_271_Fig1_HTML.png)